N/A Completed N=85 Randomized Single-blind Treatment

Impact of Humeral Component Version on Outcomes Following RTSA

Rotator Cuff Tear Arthropathy

Source: ClinicalTrials.gov NCT03111147 ↗

Enrolled (actual)

Serious AEs

4.7%

Results posted

Mar 2024

Primary outcomePrimary: Postoperative External Range of Motion (ROM) — 35; 39 degrees

Summary

The proposed study is a prospective, single-blinded, randomized trial to investigate the impact of humeral component version on shoulder range of motion and patient reported functional outcomes following reverse total shoulder arthroplasty.

Outcome Measures

Outcome	Result	p-value
PRIMARY Postoperative External Range of Motion (ROM)	35; 39	—
PRIMARY Postoperative Internal Range of Motion (ROM)	35.5; 33.5	—

Eligibility Criteria

Inclusion Criteria

Patients undergoing primary reverse total shoulder arthroplasty
Diagnosis of cuff tear arthropathy or primary OA with RCT
Intact posterior rotator cuff and subscapularis preoperatively, as determined by surgeon-administered physical exam
18 years or older

Exclusion Criteria

Revision arthroplasty
Diagnosis of rheumatoid arthritis, infection, acute trauma or instability
Minors (under 18 years of age)
Prior open shoulder surgery
Concomitant latissimus dorsi transfer
Patients not undergoing a standard of care physical therapy protocol
Pregnant, patient-reported
Cognitively impaired

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03111147). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.